ReGEN Podcast

ReGEN Podcast
Podcast Description
The Sanford Stem Cell Institute (SSCI) ReGen Podcast features engaging and innovative discussions with a focus on the following topics: stem cell science; regenerative medicine; clinical trials; research outcomes; and, space and low Earth orbit-based research. Guests include UC San Diego Sanford SSCI experts and team members, academic luminaries, Nobel laureates, and industry and government leaders in the field. The ReGen Podcast is based in San Diego, CA, and is hosted by SSCI team member Bobby Gordon.
About the Sanford Stem Cell Institute
The UC San Diego Sanford Stem Cell Institute (SSCI) is a global leader in regenerative medicine and a hub for stem cell science and innovation in space, representing six (6) research Centers, the CIRM Alpha Stem Cell Clinic, and a Brain Tumor & Neuro-Restoration Program. SSCI aims to catalyze critical basic research discoveries, translational advances, and clinical progress — terrestrially and in space — to develop and deliver novel therapeutics to patients.
Podcast Insights
Content Themes
The podcast delves into themes such as stem cell science, regenerative medicine, clinical trials, and research outcomes, with episodes covering discussions on low Earth orbit-based research and its implications for future therapeutics, as well as breakthroughs presented by keynote speakers at conferences.

The Sanford Stem Cell Institute (SSCI) ReGen Podcast features engaging and innovative discussions with a focus on the following topics: stem cell science; regenerative medicine; clinical trials; research outcomes; and, space and low Earth orbit-based research. Guests include UC San Diego Sanford SSCI experts and team members, academic luminaries, Nobel laureates, and industry and government leaders in the field. The ReGen Podcast is based in San Diego, CA, and is hosted by SSCI team member Bobby Gordon.
About the Sanford Stem Cell Institute
The UC San Diego Sanford Stem Cell Institute (SSCI) is a global leader in regenerative medicine and a hub for stem cell science and innovation in space, representing six (6) research Centers, the CIRM Alpha Stem Cell Clinic, and a Brain Tumor & Neuro-Restoration Program. SSCI aims to catalyze critical basic research discoveries, translational advances, and clinical progress — terrestrially and in space — to develop and deliver novel therapeutics to patients.

This episode’s conversation focuses on the innovative work of Dr. Catriona Jamieson, Director of the Sanford Stem Cell Institute at UC San Diego, and the Axiom-4 (Ax-4) launch. This space research mission includes the Institute’s testing of the efficacy of “rebecsnib” on tumor organoids derived from cancer stem cells of consenting patients with secondary acute myeloid leukemia, ovarian cancer, metastatic breast cancer and glioblastoma multiforme. The drug holds potential to fight 23 types of cancer — any that involve ADAR1 in their development and progression. The hope is that the investigational new drug prevents the miniature tumors from growing, as it did on Axiom Space’s previous Ax-3 mission, with cell line-derived triple negative breast cancer tumor organoids.
Hosted by Bobby Gordon
This episode was recorded on June 6, 2025, and information presented is accurate as of this date.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.